Jubilant Pharmova Ltd

Jubilant Pharmova Ltd

₹ 638 -1.81%
12 Apr 4:05 p.m.
About

Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs.[1]

Key Points

Business Segment FY23

a. Radiopharma (~40%): Radiopharmaceuticals (including radiopharmacies)
b. Allergy Immunotherapy (~10%): Allergy Therapy products
c. Contract Development and Manufacturing Organisation - Sterile Injectables (18%): Contract manufacturing of Sterile Injectables and Non-Sterile products
d. Generics (12%): Solid Dosage Formulations
e. Contract Research, Development, and Manufacturing Organisation (19%): (i) Drug discovery services and (ii) Active Pharmaceutical Ingredients
f. Proprietary Novel Drugs (~1%): Patient-focused biopharmaceutical business working to address unmet medical needs in oncology and autoimmune diseases. [1]

  • Market Cap 10,125 Cr.
  • Current Price 638
  • High / Low 666 / 299
  • Stock P/E 277
  • Book Value 340
  • Dividend Yield 0.78 %
  • ROCE 3.13 %
  • ROE -6.89 %
  • Face Value 1.00

Pros

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -3.53% over past five years.
  • Company has a low return on equity of 5.80% over last 3 years.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
1,771 1,580 1,635 1,657 1,311 1,528 1,452 1,600 1,552 1,678 1,587 1,680 1,677
1,282 1,205 1,269 1,319 1,116 1,280 1,259 1,384 1,408 1,459 1,419 1,438 1,459
Operating Profit 490 375 365 338 194 247 192 216 144 219 168 242 218
OPM % 28% 24% 22% 20% 15% 16% 13% 14% 9% 13% 11% 14% 13%
84 52 4 4 6 -2 11 -44 10 21 9 19 49
Interest 46 43 35 35 37 40 40 42 51 56 62 66 71
Depreciation 96 86 88 100 93 101 95 94 94 271 90 97 95
Profit before tax 431 297 247 208 70 106 69 36 9 -86 25 98 101
Tax % 28% 28% 35% 31% 28% 44% 32% 87% 285% -16% 76% 37% 34%
310 214 160 143 51 59 47 5 -16 -100 6 62 66
EPS in Rs 19.46 13.43 10.08 8.97 3.20 3.74 2.96 0.34 -0.98 -6.15 0.40 3.92 4.19
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
4,270 5,132 5,762 5,751 5,749 5,861 7,518 9,111 5,976 6,099 6,130 6,282 6,622
3,379 4,134 4,763 5,141 4,493 4,510 5,995 7,367 4,428 4,695 4,980 5,503 5,775
Operating Profit 891 999 999 610 1,256 1,352 1,522 1,744 1,548 1,403 1,150 779 847
OPM % 21% 19% 17% 11% 22% 23% 20% 19% 26% 23% 19% 12% 13%
-318 -93 -173 86 4 19 36 -249 225 263 8 -9 98
Interest 238 311 337 368 371 341 284 220 200 184 145 188 255
Depreciation 221 254 281 288 347 291 415 371 340 349 382 554 552
Profit before tax 114 341 207 40 542 738 859 904 1,233 1,133 630 28 138
Tax % 60% 45% 34% 200% 29% 22% 26% 36% 27% 26% 34% 334%
46 189 138 -40 387 575 634 577 898 836 413 -65 34
EPS in Rs 0.91 9.59 6.84 -3.63 24.60 36.14 40.35 36.06 56.39 52.47 25.98 -3.83 2.36
Dividend Payout % 328% 31% 43% -83% 12% 8% 7% 12% 9% 10% 19% -130%
Compounded Sales Growth
10 Years: 2%
5 Years: -4%
3 Years: 2%
TTM: 8%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -38%
Stock Price CAGR
10 Years: 16%
5 Years: 1%
3 Years: -4%
1 Year: 114%
Return on Equity
10 Years: 11%
5 Years: 10%
3 Years: 6%
Last Year: -7%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 16 16 15 16 16 16 16 16 16 16 16 16 16
Reserves 2,241 2,460 2,611 2,438 2,951 3,420 4,071 4,793 5,588 4,726 5,303 5,383 5,394
3,818 4,245 4,395 4,793 4,493 4,045 3,469 4,840 4,808 2,830 3,192 3,677 3,668
1,688 1,650 1,842 1,372 1,280 1,417 1,902 1,670 1,898 1,192 1,319 1,853 2,322
Total Liabilities 7,763 8,371 8,864 8,619 8,740 8,899 9,457 11,319 12,310 8,763 9,830 10,929 11,400
4,460 4,967 5,099 4,911 5,104 5,107 5,401 5,648 6,340 4,609 4,871 5,183 5,989
CWIP 686 437 472 597 611 684 671 901 768 897 1,090 1,561 1,095
Investments 19 26 34 40 85 103 124 115 69 241 239 256 266
2,598 2,941 3,259 3,071 2,939 3,006 3,262 4,654 5,133 3,017 3,631 3,928 4,050
Total Assets 7,763 8,371 8,864 8,619 8,740 8,899 9,457 11,319 12,310 8,763 9,830 10,929 11,400

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
707 970 772 783 1,099 1,268 1,303 1,122 1,543 1,784 838 661
-596 -504 -164 -362 -309 -465 -614 -1,018 -267 -727 -323 -474
-889 -450 -414 -503 -843 -686 -901 657 -1,050 -1,709 -33 -157
Net Cash Flow -778 17 194 -82 -52 117 -212 761 225 -652 482 30

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 56 50 51 52 60 63 55 51 79 49 55 56
Inventory Days 231 198 200 169 207 223 177 147 463 268 308 268
Days Payable 190 115 107 99 106 137 145 106 273 124 139 160
Cash Conversion Cycle 97 133 144 122 162 149 87 92 268 194 224 165
Working Capital Days 50 40 -16 45 52 66 57 65 105 78 86 77
ROCE % 11% 12% 11% 6% 13% 15% 15% 16% 15% 12% 10% 3%

Shareholding Pattern

Numbers in percentages

Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
50.68% 50.68% 50.68% 50.68% 50.68% 50.68% 50.67% 50.67% 50.67% 50.67% 50.67% 50.67%
25.69% 24.82% 23.14% 23.18% 23.45% 23.47% 23.06% 23.38% 23.22% 23.20% 23.20% 20.29%
1.28% 1.75% 1.03% 1.06% 0.63% 0.62% 1.60% 1.62% 1.62% 1.63% 1.64% 2.89%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.24% 0.00% 0.00% 0.00%
22.29% 22.68% 25.09% 25.01% 25.18% 25.17% 24.59% 24.20% 23.11% 23.91% 23.89% 25.56%
0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.13% 0.13% 0.59% 0.59% 0.58%
No. of Shareholders 61,94287,4931,13,7761,09,4201,08,0631,09,4101,05,6321,00,21297,93593,37589,37686,588

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls